Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Methyldopa
- Therapeutic area
- Cardiovascular
- Drug class
- Antihypertensive medicines
- ATC
- C02AB
- Strength
- 250 mg
- Dosage form
- Tablet
- Pack
- 10x10’s
- Registration no.
- 030941
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-27 02:57
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 1,538.42 to 1,614.41 (+4.9%) between 22 Aug 2025 and 20 Aug 2026 · 2 official price records · pack 10x10’s
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Normet .(SRO 229 250 mg, 10x10’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/normet-sro-229-250-mg-030941-10x10s-valor-pharmaceuticals/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,614.41 | 2026-08-20 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 1,538.42 | 2025-08-22 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 030941Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
